Physician profile
Nancy B Lipsitz
NPI 1972695393
$2,947.45
in general payments reported to CMS, 2019-2025
28 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.55 · 2020: $34.71 · 2021: $589 · 2022: $663 · 2023: $545 · 2024: $689 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.61 |
| Education | $269.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $469.77 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $469.70 | 2019-2023 | |
| Aspira Women'S Health INC | $448.72 | 2021-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $220.73 | 2020-2025 | |
| Biogen, INC. | $167.03 | 2024-2025 | Zurzuvae |
| Channel Medsystems, INC. | $146.28 | 2023 | |
| Medtronic, INC. | $145.24 | 2023-2024 | V-Loc 180, Truclear |
| Organon LLC | $134.83 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $116.53 | 2019-2025 | Endosee, Paragard T 380a |
| Exeltis, USA INC. | $63.20 | 2021-2024 | Slynd |
| Hologic INC | $50.95 | 2025 | 3dimensions |
| Millicent US INC | $45.65 | 2022-2024 | Intrarosa |
| Hologic Sales and Service, LLC | $44.61 | 2021-2024 | Acessa Provu System |
| Therapeuticsmd, INC. | $43.11 | 2022 | |
| Pfizer INC. | $41.88 | 2022-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $41.02 | 2021 | |
| Mylan Pharmaceuticals INC. | $40.20 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $37.10 | 2021-2024 | Capvaxive, Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $32.39 | 2022-2023 | |
| Amag Pharmaceuticals, INC. | $30.98 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $28.97 | 2024 | |
| Evofem Biosciences, INC. | $27.58 | 2021-2022 | |
| Ethicon US, LLC | $26.82 | 2021 | |
| Exact Sciences Corporation | $18.73 | 2023 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $16.92 | 2025 | Pico |
| Allergan, INC. | $13.79 | 2019 | |
| Boston Scientific Corporation | $12.84 | 2022 | |
| Olympus America INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Lipsitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.